Gu Caifeng, Shen Jie, Zhang Feng, Chen Junfeng
The Centre of Emergency and ICU, Jinshan Hospital Affiliated to Fudan University Shanghai, China.
Int J Clin Exp Pathol. 2017 Nov 1;10(11):10883-10891. eCollection 2017.
The present study was designed to assess the molecular mechanism of Dichlorvos (DDVP)-induced hepatic cell toxicity in vitro using HepaRG cells. The cytotoxicity was determined by cell viability, apoptosis portion, and reactive oxygenspecies (ROS) generation. The results indicated that DDVP treatment significantly inhibited cell growth, induced cell apoptosis and promoted the production of ROS on HepaRG cells. Microarray analysis showed that miR-181a was significantly upregulated in HepaRG cells treated with DDVP. Furthermore, we found that miR-181a downregulation has a remedy effect on DDVP-induced cell toxicity, while miR-181a overexpression augments the DDVP-induced hepatic cell apoptosis and ROS production. Furthermore studies showed that miR-181a directly targeted Bcl-2, and Bcl-2 downregulation inhibited the remedy effect of miR-181a inhibitor on DDVP induced cell toxicity. It is, therefore, concluded that miR-181a knockdown could protect hepatic cells from DDVP induced oxidative stress and apoptosis by targeting bcl-2.
本研究旨在利用HepaRG细胞评估敌敌畏(DDVP)体外诱导肝细胞毒性的分子机制。通过细胞活力、凋亡比例和活性氧(ROS)生成来测定细胞毒性。结果表明,DDVP处理显著抑制HepaRG细胞的生长,诱导细胞凋亡并促进ROS的产生。微阵列分析显示,在DDVP处理的HepaRG细胞中miR-181a显著上调。此外,我们发现下调miR-181a对DDVP诱导的细胞毒性有补救作用,而miR-181a过表达则增强了DDVP诱导的肝细胞凋亡和ROS产生。进一步的研究表明,miR-181a直接靶向Bcl-2,Bcl-2的下调抑制了miR-181a抑制剂对DDVP诱导的细胞毒性的补救作用。因此,得出结论,敲低miR-181a可通过靶向bcl-2保护肝细胞免受DDVP诱导的氧化应激和凋亡。